Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Clear Cell Renal Cell Carcinoma with Biallelic Inactivation of CDKN2A/B on 9p21 have Distinct Gene Expression Signature and are Associated with Poor Prognosis

Andrew H. Girgis
doi: https://doi.org/10.1101/143180
Andrew H. Girgis
1Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Purpose The clinical implications of biallelic inactivation of CDKN2A/B in clear cell renal cell carcinoma (ccRCC) and relevant dysregulated biological pathways and gene signatures were investigated.

Materials and Methods Data were obtained from the TCGA data set and validated using Project GENIE and previously published dataset. CDKN2A/B allelic status was classified into 3 groups, including biallelic CDKN2A/B inactivation (homozygous deletion or combined heterozygous deletion and mutation), monoallelic CDKN2A/B loss (heterozygous deletion or mutation) and absent CDKN2A/B allelic loss. Univariate and multivariate cancer-specific survival and disease-free survival analyses were performed. Integrated analyses of copy number, gene expression (mRNA and miRNA), protein expression and methylation changes were conducted.

Results Of 440 patients with ccRCC 17 (3.9%) had biallelic CDKN2A/B inactivation and 116 (26.4%) had monoallelic CDKN2A/B loss. CDKN2A/B allelic inactivation was associated with late tumor stage, high histological grade, presence of metastasis and greater tumor size. Patients with biallelic deletion of CDKN2A/B showed significantly worse cancer-specific survival and disease-free survival (p<0.0001). Significant co-occurrence of MTAP homozygous deletion was observed in CDKN2A/B biallic inactivated tumors (46.7%; p<0.001). Significant underexpression of CDKN2A/B was observed in biallelic inactivated tumors at the mRNA and protein levels. miR-21 was the most highly expressed miRNA in biallelic inactivated tumors. Biallelic inactivated tumors were significantly enriched for genes related to activation of ATR in response to replication stress and miR-21 target genes.

Conclusions CDKN2A/B biallelic inactivation may be a prognostic marker for ccRCC and is associated with distinct dysregulation of gene expression signatures.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 29, 2017.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clear Cell Renal Cell Carcinoma with Biallelic Inactivation of CDKN2A/B on 9p21 have Distinct Gene Expression Signature and are Associated with Poor Prognosis
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clear Cell Renal Cell Carcinoma with Biallelic Inactivation of CDKN2A/B on 9p21 have Distinct Gene Expression Signature and are Associated with Poor Prognosis
Andrew H. Girgis
bioRxiv 143180; doi: https://doi.org/10.1101/143180
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Clear Cell Renal Cell Carcinoma with Biallelic Inactivation of CDKN2A/B on 9p21 have Distinct Gene Expression Signature and are Associated with Poor Prognosis
Andrew H. Girgis
bioRxiv 143180; doi: https://doi.org/10.1101/143180

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4397)
  • Biochemistry (9619)
  • Bioengineering (7114)
  • Bioinformatics (24917)
  • Biophysics (12644)
  • Cancer Biology (9982)
  • Cell Biology (14390)
  • Clinical Trials (138)
  • Developmental Biology (7981)
  • Ecology (12136)
  • Epidemiology (2067)
  • Evolutionary Biology (16012)
  • Genetics (10941)
  • Genomics (14768)
  • Immunology (9891)
  • Microbiology (23720)
  • Molecular Biology (9495)
  • Neuroscience (51027)
  • Paleontology (370)
  • Pathology (1544)
  • Pharmacology and Toxicology (2688)
  • Physiology (4031)
  • Plant Biology (8687)
  • Scientific Communication and Education (1512)
  • Synthetic Biology (2403)
  • Systems Biology (6450)
  • Zoology (1346)